Enhancing Clinical Trials for Faster, More Predictable Outcomes with WCG Study Accelerator

CARY, N.C., May 28, 2025 /PRNewswire/ -- WCG, a global leader in providing solutions that measurably improve and accelerate clinical research, today announced the launch of WCG Study Accelerator, an innovative, integrated solution purpose-built to streamline clinical trial processes and improve outcomes for sponsors and institutions worldwide. Designed to tackle the operational challenges inherent to clinical trials, WCG Study Accelerator enables faster, more predictable study execution by aligning site selection, ethical review, and recruitment and retention efforts under one cohesive strategy to effectively drive research to results.

Drawing on unparalleled operational intelligence and real-time feedback, WCG Study Accelerator reduces risk, avoids underperforming sites, and compresses study timelines by as much as 20%. Offering a data-driven approach to site identification and feasibility, ethical review, and recruitment and retention, this powerful solution provides sponsors with the ability to make smarter site choices and achieve higher enrollment efficiencies.

"With the launch of WCG Study Accelerator, we are addressing the well-known bottlenecks that have plagued clinical trials for years," remarked Sam Srivastava, chief executive officer, WCG. "Our solution exemplifies our commitment to innovation and customer-centricity by providing a model that propels trial execution forward with precision, speed, and integrity. We understand the needs of the industry and are delivering a thoughtful solution to anticipate and solve the challenges of our clients so they can better serve trial participants."

"Clinical trial leaders need tools that simplify execution while increasing efficiency across all phases," noted Mark McDonald, chief operations officer, WCG. "Study Accelerator not only provides a structured framework for executing trials efficiently, but also embeds flexibility and insights by streamlining site selection, and participant enrollment and engagement processes. The solution combines advanced technology with hands-on support to ensure seamless implementation and execution, even for highly specialized or complex protocols. This truly enables smarter, faster trials."

For more information on how WCG Study Accelerator can empower your clinical trial efforts, visit https://www.wcgclinical.com/solutions/study-accelerator/.

About WCG

WCG is at the forefront of accelerating clinical research worldwide, serving as the trusted and preferred partner to biopharmaceutical and medical device companies, contract research organizations (CROs), research institutions, and site partners. Offering a unique combination of expertise, next-generation data and insights, and tech-enabled solutions, WCG reduces complexity and optimizes study operations and outcomes while maintaining the highest standards of human participant protection. For more than 55 years, WCG has maintained a relentless commitment to efficiency, safety, and impact, empowering clinical trials to deliver life-improving therapies swiftly. For more information, please visit wcgclinical.com or follow us on LinkedIn or X @WCGClinical.

SOURCE WCG